Serotonin transporter polymorphisms affect human blood glucose control

Biochem Biophys Res Commun. 2005 Sep 9;334(4):1165-71. doi: 10.1016/j.bbrc.2005.07.022.

Abstract

We measured the effect of nutritional intervention on clinical data, including fasting blood glucose (FBG), and their association with polymorphisms of the serotonin transporter-linked polymorphic region (5-HTTLPR) which might affect adherence. Enrolled in the intervention program were 264 Japanese women not on medication for diabetes, hypercholesterolemia or hypertension. The 5-HTTLPR allele (S and L) frequencies among the subjects differed markedly from those of Caucasians: SS (n = 183), LS (n = 69), and LL (n = 12). The decrease in FBG (DeltaFBG) from the beginning to the end of the program (11 weeks; short-term study), and DeltaFBG from the beginning to a follow-up check performed between 2002 and 2004 (average of 23 years later; long-term study) was calculated. The SS homozygotes of 5-HTTLPR showed larger DeltaFBG (P = 0.01 and P < 0.0001 in the short- and long-term studies, respectively) than DeltaFBG with other genotypes.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Blood Glucose / analysis*
  • Body Mass Index
  • DNA Mutational Analysis / methods
  • Female
  • Genetic Predisposition to Disease / epidemiology
  • Genetic Testing / methods*
  • Humans
  • Incidence
  • Japan / epidemiology
  • Membrane Glycoproteins / genetics*
  • Membrane Transport Proteins / genetics*
  • Middle Aged
  • Nerve Tissue Proteins / genetics*
  • Obesity / genetics*
  • Obesity / metabolism*
  • Polymorphism, Genetic*
  • Risk Assessment / methods*
  • Risk Factors
  • Serotonin Plasma Membrane Transport Proteins
  • Statistics as Topic

Substances

  • Blood Glucose
  • Membrane Glycoproteins
  • Membrane Transport Proteins
  • Nerve Tissue Proteins
  • SLC6A4 protein, human
  • Serotonin Plasma Membrane Transport Proteins